The coverage decision from Palmetto GBA includes all fee-for-service Medicare patients with advanced cancers who meet its clinical criteria for genomic profiling to help select the most appropriate treatment, but don’t have tissue samples for molecular profiling.
COVID-19 infects cells by binding to the ACE2 protein, found on the surface of cells in the lungs, cardiovascular system, kidneys, and in the gut. The research says the biggest predictor of high ACE2 levels is being male.
Researchers show that mice harboring the butyrate-producing bacteria Roseburia eating a high-fiber diet suffered from less atherosclerosis
Researchers Find New Genetic Variants Linked to Atrial Fibrillation, Suggesting New Treatment Targets
Exact Sciences announced that the U.S. Food and Drug Administration (FDA) approved its noninvasive colorectal cancer screening test, Cologuard, for eligible average-risk individuals ages...
Thermo Fisher Scientific completed the listing of its Ion PGM Dx next-generation sequencing (NGS) system with the FDA for clinical use as a class...
The immune checkpoint molecule could represent a promising target for pancreatic cancer, one of the deadliest and hardest to treat cancers
The rapid advancement of NGS in clinical diagnostics underscores the need for more assay standardization.
Most drugs used for COVID-19 treatments are not being used for the indication they were originally designed for and there has been much public debate about how effective or safe some of them are.
Leveraging CRISPR-Cas9 scientists generate an atlas of genes essential for the normal growth and maintenance of human pluripotent stem cells